Buprenorphine—used to treat opioid use disorder—is the only drug that ever came with federal limits on the number of patients a provider could care for. It also came with restrictions on the types of clinicians who could prescribe it. Rules requiring the so-called “x-waiver” for prescribing clinicians were ultimately repealed in December 2022. Since then, providers have been able to offer buprenorphine to any number of patients who need addiction treatment and a path to …
Read More![Providers Slow to Consider Buprenorphine For Addiction Treatment Providers Slow to Consider Buprenorphine For Addiction Treatment](https://www.jucm.com/wp-content/uploads/2024/01/Middle-Aged-White-Male-Stressed-with-Hands-Covering-Face-While-Speaking-to-White-Male-Provider-Depression-Guilt-Addiction-Buprenorphine-380x253-1.jpg)